Expertise in
2
conditions

Naghmeh Radhakrishna

St Vincent's Hospital
Melbourne, VIC, AU 
Expertise in
2
conditions
St Vincent's Hospital
Melbourne, VIC, AU 

Overview

Naghmeh Radhakrishna practices practicing medicine in Melbourne, Australia.

Radhakrishna is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Eosinophilic Asthma, Asthma, Vocal Cord Dysfunction, and Gastroesophageal Reflux Disease (GERD).

They are actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.

Locations

St Vincent's Hospital
Melbourne, VIC, Australia
Other Locations
Northern Health
Epping, NSW, Australia
Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3

27 Total Publications

Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
Journal: Respiratory medicine
Published: May 30, 2025

Frequently Asked Questions about Naghmeh Radhakrishna

Is Naghmeh Radhakrishna a top-rated expert for Eosinophilic Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Naghmeh Radhakrishna is classified as an Distinguished expert for Eosinophilic Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Naghmeh Radhakrishna participate in research or clinical trials?

Yes. Naghmeh Radhakrishna has published 27 articles and abstracts on conditions like Eosinophilic Asthma. You can view a list of Naghmeh Radhakrishna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Radhakrishna's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile